A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir dipivoxil (ADV) for treatment naive patients with chronic hepatitis B (CHB): Week 52 analysis

被引：64

作者：

Sung, JJY

Lai, JY

Zeuzem, S

Chow, WC

Heathcote, E

Perrillo, R

Brosgart, C

Woessner, M

Scott, SA

Campbell, FM

机构：

[1] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China

[2] Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China

[3] Univ Hosp, Hamburg, Germany

[4] Singapore Gen Hosp, Singapore 0316, Singapore

[5] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada

[6] Alton L Oschner Hosp, Singapore, Singapore

[7] Gilead Sci Inc, Foster City, CA 94404 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(03)80485-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：25 / 26

页数：2